News and Announcements
Strong Interest for Altech at the International Sapphire Industry Exhibition
- Published July 14, 2016 10:17AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
14th July 2016, ASX Announcement
Highlights:
- Strong interest for Altech’s entry into the high purity alumina market
- Altech’s proposed nano particle size HPA product range well received
- Vertically integrated production model will ensure security of quality of HPA supply
- Forecast tightening of supply side of the HPA market as demanded rapidly expands
- HPA analytical and production data available to end-users on-line
Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to provide a summary of its recent attendance at the 2nd International Sapphire Industry and Touch Screen Technology Exhibition in Shenzen, China (June 23-25 2016).
Altech’s presentation at the exhibition generated strong interest from synthetic sapphire producers, who welcome the prospect of the Company’s entry into the high purity alumina (HPA) market via its proposed 4,000tpa Malaysian HPA plant.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
